Page last updated: 2024-10-28

hexamethonium and Recrudescence

hexamethonium has been researched along with Recrudescence in 2 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saunders, PR1
Miceli, P1
Vallance, BA1
Wang, L1
Pinto, S1
Tougas, G1
Kamath, M1
Jacobson, K1
Murthy, S1
Dinoso, VP1
Natrajan, R1

Other Studies

2 other studies available for hexamethonium and Recrudescence

ArticleYear
Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat.
    Autonomic neuroscience : basic & clinical, 2006, Jan-30, Volume: 124, Issue:1-2

    Topics: Acute Disease; Animals; Atropine; Autonomic Pathways; Bretylium Tosylate; CD3 Complex; Colitis; Colo

2006
Neurohormonal mechanisms of cigarette smoke-induced duodenal mucosal bicarbonate secretion in the rat.
    Peptides, 1997, Volume: 18, Issue:7

    Topics: Animals; Atropine; Bicarbonates; Brunner Glands; Duodenal Ulcer; Duodenum; Gastrointestinal Hormones

1997